INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain1h ago

Results

76,375 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
HP
Harwood Michael PhilipDirector
CIACITIZENS, INC.
Small acquisition
L$498
92 sh
Apr 7, 2026Jun 22, 2026
Page 788 of 1910
← PrevNext →
traded Apr 7, 2026
+76d
SEC Form 4

Evidence

24
RM
Russell Robert MichaelChief Financial Officer
ARQQArqit Quantum Inc.
Grant or award
A—
5,202 sh
Apr 1, 2026Jun 22, 2026
traded Apr 1, 2026
+82dSEC Form 4

Evidence

23
BB
Brown BruceDirector
INVInnventure, Inc.
Grant or award
A—
18.2K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
KN
Kelman NaomiDirector
EYENational Vision Holdings, Inc.
Grant or award
A—
11.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
4,203 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
CE
Choi EmilieDirector
OKTAOkta, Inc.
Option exercise
M—
2,487 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
MV
Malyala VikranthSVP, Chief Business Officer
SMCISuper Micro Computer, Inc.
Option exercise
M—
7,500 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
SC
Simons Anna CDirector
ADSKAutodesk, Inc.
Grant or award
A—
466 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
FR
Frieson RonDirector
AKBAAkebia Therapeutics, Inc.
Grant or award
A—
35.7K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
TS
Trickett SaraChief Legal Officer
WEXWEX Inc.
Option exercise
M—
75 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

23
TM
Taylor MaryDirector
CIACITIZENS, INC.
Option exercise
M—
12.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

22
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$337K
39.8K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

22
MV
Malyala VikranthSVP, Chief Business Officer
SMCISuper Micro Computer, Inc.
Tax withholding
F$78K
2,825 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$71K
488 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$117K
806 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

21
MT
Ming TracyFinancial Controller
IDAIT Stamp Inc
Grant or award
A—
2,669 sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

21
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.13M
60.4K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

21
PD
Poillon DianeDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
1,000 sh
Jun 19, 2026Jun 22, 2026
traded Jun 19, 2026
+3dSEC Form 4

Evidence

20
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Small acquisition
L$298
54 sh
May 5, 2026Jun 22, 2026
traded May 5, 2026
+48dSEC Form 4

Evidence

20
CM
Cossery Jean-MichelDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

20
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

20
OV
Ossipow VincentDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
TH
Tan Kwang HooiChief Operating Officer
FLEXFLEX LTD.
Open-market sale
SELL$15K
100 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
MD
Mounts Gonzales DavidDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise
M—
27.1K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$2,487
17 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
DA
Dennis Phillip AndrewChief Medical Officer
NBPNovaBridge Biosciences
Option exercise
M—
10.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
DA
Dennis Phillip AndrewChief Medical Officer
NBPNovaBridge Biosciences
Option exercise
M—
23.7K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TE
Toro Valencia Juan EstebanDirector
CIBGrupo Cibest S.A.
Grant or award
A$4,104
520 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
WA
Wong AliceDirector
HLHECLA MINING CO/DE/
Other acquisition or disposition
J$125K
14.4K sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

19
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
4,203 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
ZN
Zapata Zuluaga NicolasDirector
CIBGrupo Cibest S.A.
Grant or award
A$4,139
524 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Option exercise
M—
12.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TM
Taylor MaryDirector
CIACITIZENS, INC.
Small acquisition
L$497
95 sh
May 29, 2026Jun 22, 2026
traded May 29, 2026
+24dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
5,418 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
3,401 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DO
Donnally James ODirector
INVInnventure, Inc.
Gift
G—
22.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DM
Dawsey James MDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$14K
373 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,506
195 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$281K
4,582 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence